Non-medical prescription stimulant use: Investigating modifiable risk factors

被引:11
|
作者
Looby, Alison [1 ]
Beyer, Danielle L. [1 ]
Zimmerman, Lauren [1 ]
机构
[1] Univ N Dakota, Dept Psychol, Grand Forks, ND 58202 USA
关键词
Cognitive enhancement; expectancy effects; GPA; non-medical prescription stimulant use; self-efficacy; COLLEGE-STUDENTS; ILLICIT USE; PREVALENCE; DIVERSION;
D O I
10.3109/16066359.2014.946411
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Many college students report non-medical prescription stimulant use (NPS), frequently citing cognitive enhancement benefits as their primary motive for use. One known risk factor for NPS is low grade point average (GPA), which may promote poor academic self-efficacy, leading to NPS. This may be particularly true for students who hold strong cognitive enhancement expectations for NPS. This study aimed to examine these variables as modifiable risk factors for NPS and to examine their interactive effects on intention to use. One hundred fifty-four undergraduate students completed measures to assess demographics, history of NPS and related expectancy effects and self-efficacy for learning. Strong cognitive enhancement expectancies and low academic self-efficacy were found to predict intention to engage in NPS after controlling for other known risk factors. Moreover, students with low GPA and strong cognitive enhancement expectancies appear to be particularly at risk for intent to engage in NPS. Unlike most known risk factors for NPS, expectancy effects and self-efficacy are able to be altered though intervention. Future research should focus on the development of interventions to modify these cognitions.
引用
收藏
页码:143 / 147
页数:5
相关论文
共 50 条
  • [31] Normative perceptions of non-medical stimulant use: Associations with actual use and hazardous drinking
    Kilmer, Jason R.
    Geisner, Irene Markman
    Gasser, Melissa L.
    Lindgren, Kristen P.
    ADDICTIVE BEHAVIORS, 2015, 42 : 51 - 56
  • [32] Factors associated with non-medical use of prescription drugs among individuals with a legitimate prescription for medical purposes: A population-based study
    Pylvas-Korolainen, Minna
    Karjalainen, Karoliina
    Lintonen, Tomi
    NORDIC STUDIES ON ALCOHOL AND DRUGS, 2022, 39 (01) : 50 - 63
  • [33] NON-MEDICAL USE OF PRESCRIPTION DRUGS, DRUGS OF ABUSE, AND SEXUAL RISK BEHAVIOR IN YOUNG ADULTS
    Benotsch, Eric G.
    Luckman, Diana
    Martin, Aaron
    Koester, Steve
    Cejka, Anna
    ANNALS OF BEHAVIORAL MEDICINE, 2010, 39 : 160 - 160
  • [34] Mental illnesses as a potential risk factor for non-medical use of prescription opioids: a narrative review
    De Guzman, Keshia R.
    Puljevic, Cheneal
    Snoswell, Centaine L.
    JOURNAL OF PHARMACY PRACTICE AND RESEARCH, 2022, 52 (01) : 19 - 25
  • [35] The non-medical switching of prescription medications
    Dolinar, Richard
    Kohn, Christine
    Lavernia, Frank
    Nguyen, Elaine
    POSTGRADUATE MEDICINE, 2019, 131 (05) : 335 - 341
  • [36] Alcohol, cannabis, and cigarette use and non-medical prescription drug use stages
    Arterberry, Brooke J.
    Horbal, Steven R.
    Lin, Hsien-Chang
    Buu, Anne
    DRUG AND ALCOHOL DEPENDENCE, 2017, 171 : E11 - E11
  • [37] Non-medical opioid use in youth: Gender differences in risk factors and prevalence
    Osborne, Vicki
    Serdarevic, Mirsada
    Crooke, Hannah
    Striley, Catherine
    Cottler, Linda B.
    ADDICTIVE BEHAVIORS, 2017, 72 : 114 - 119
  • [38] Pill popping problems: The non-medical use of stimulant medications in an undergraduate sample
    Gallucci, Andrew R.
    Usdan, Stuart L.
    Martin, Ryan J.
    Bolland, Kathleen A.
    DRUGS-EDUCATION PREVENTION AND POLICY, 2014, 21 (03) : 181 - 188
  • [39] Age of First Use of Prescription Opioids and Prescription Opioid Non-Medical Use among Older Adolescents
    Osborne, Vicki
    Serdarevic, Mirsada
    Striley, Catherine W.
    Nixon, Sara J.
    Winterstein, Almut G.
    Cottler, Linda B.
    SUBSTANCE USE & MISUSE, 2020, 55 (14) : 2420 - 2427
  • [40] Health harms of non-medical prescription opioid use: A systematic review
    WERB, D. A. N.
    SCHEIM, A. Y. D. E. N. I.
    SOIPE, A. Y. O. R. I. N. D. E.
    AEBY, S. A. M. A. N. T. H. A.
    RAMMOHAN, I. N. D. H. U.
    FISCHER, B. E. N. E. D. I. K. T.
    HADLAND, S. C. O. T. T. E.
    MARSHALL, B. R. A. N. D. O. N. D. L.
    DRUG AND ALCOHOL REVIEW, 2022, 41 (04) : 941 - 952